Information about Fintepla for patients and their caregivers

This website has been designed to give information about Fintepla (fenfluramine) to patients who have been prescribed Fintepla, and also to caregivers of patients who have been prescribed Fintepla.

About Dravet syndrome

In About Dravet syndrome you can learn more about the condition and the seizures that are associated with it

Getting started

You can find out about how to take Fintepla in Getting started

What to look out for: possible side effects

In this section you can learn about common side effects of Fintepla. There is also information which can help you to report any side effects of Fintepla

Questions you may have

Answers to some of the questions that patients and their caregivers may have

Important safety information

The Important safety information section includes details on how Fintepla will be prescribed and the need for patients to have echocardiograms (ECHOs) to monitor heart health

Help and support

In Help and support you can find useful information about how to contact patient organisations local to you

This website is intended for patients in Europe who have been prescribed Fintepla and their caregivers

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you or the person you care for may experience. See the What to look out for section for how to report side effects.

Fintepla is a medicine which is prescribed to treat the seizures that patients with Dravet syndrome can experience. Fintepla is used with other drugs to treat seizures in Dravet syndrome patients aged 2 years of age and older.

Dravet syndrome is a rare form of epilepsy which usually starts when a child is less than 1 year old. Patients who suffer from it often have very frequent and severe seizures. You can learn more about Dravet syndrome here.